Lupus refractory pleural effusion: Transient response to intravenous immunoglobulins

E. Ben-Chetrit, Chaim Putterman, Y. Naparstek

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

A patient with systemic lupus erythematosus complicated by refractory bilateral pleural effusions is described. High dose corticosteroids with azathioprine, as well as intrapleural instillation of corticosteroids, proved ineffective in management. As our patient remained severely symptomatic and required repeated thoracocentesis, a therapeutic trial of intravenous immunoglobulins (IVIG) was attempted. IVIG had a beneficial effect, although of a transient and partial nature. Despite the results achieved, it seems that IVIG has limited value in treating lupus pleural effusion.

Original languageEnglish (US)
Pages (from-to)1635-1637
Number of pages3
JournalJournal of Rheumatology
Volume18
Issue number10
StatePublished - 1991
Externally publishedYes

Fingerprint

Intravenous Immunoglobulins
Pleural Effusion
Adrenal Cortex Hormones
Azathioprine
Systemic Lupus Erythematosus
Therapeutics

Keywords

  • intravenous immunoglobulins
  • pleural effusion
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Lupus refractory pleural effusion : Transient response to intravenous immunoglobulins. / Ben-Chetrit, E.; Putterman, Chaim; Naparstek, Y.

In: Journal of Rheumatology, Vol. 18, No. 10, 1991, p. 1635-1637.

Research output: Contribution to journalArticle

@article{0bbeae04585e40a485f53dbd070379aa,
title = "Lupus refractory pleural effusion: Transient response to intravenous immunoglobulins",
abstract = "A patient with systemic lupus erythematosus complicated by refractory bilateral pleural effusions is described. High dose corticosteroids with azathioprine, as well as intrapleural instillation of corticosteroids, proved ineffective in management. As our patient remained severely symptomatic and required repeated thoracocentesis, a therapeutic trial of intravenous immunoglobulins (IVIG) was attempted. IVIG had a beneficial effect, although of a transient and partial nature. Despite the results achieved, it seems that IVIG has limited value in treating lupus pleural effusion.",
keywords = "intravenous immunoglobulins, pleural effusion, systemic lupus erythematosus",
author = "E. Ben-Chetrit and Chaim Putterman and Y. Naparstek",
year = "1991",
language = "English (US)",
volume = "18",
pages = "1635--1637",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "10",

}

TY - JOUR

T1 - Lupus refractory pleural effusion

T2 - Transient response to intravenous immunoglobulins

AU - Ben-Chetrit, E.

AU - Putterman, Chaim

AU - Naparstek, Y.

PY - 1991

Y1 - 1991

N2 - A patient with systemic lupus erythematosus complicated by refractory bilateral pleural effusions is described. High dose corticosteroids with azathioprine, as well as intrapleural instillation of corticosteroids, proved ineffective in management. As our patient remained severely symptomatic and required repeated thoracocentesis, a therapeutic trial of intravenous immunoglobulins (IVIG) was attempted. IVIG had a beneficial effect, although of a transient and partial nature. Despite the results achieved, it seems that IVIG has limited value in treating lupus pleural effusion.

AB - A patient with systemic lupus erythematosus complicated by refractory bilateral pleural effusions is described. High dose corticosteroids with azathioprine, as well as intrapleural instillation of corticosteroids, proved ineffective in management. As our patient remained severely symptomatic and required repeated thoracocentesis, a therapeutic trial of intravenous immunoglobulins (IVIG) was attempted. IVIG had a beneficial effect, although of a transient and partial nature. Despite the results achieved, it seems that IVIG has limited value in treating lupus pleural effusion.

KW - intravenous immunoglobulins

KW - pleural effusion

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0026337969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026337969&partnerID=8YFLogxK

M3 - Article

C2 - 1765995

AN - SCOPUS:0026337969

VL - 18

SP - 1635

EP - 1637

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -